Recently, Guangdong released the list of winners of the science and technology award for medical industry in 2018.

Baiyunshan Chenliji, a GPHL subsidiary, took home first place with its industrialization project for the patent technology of Bu Pi Yi Chang Wan, a type of TCM to cure diarrhea, chronic colitis and ulcerative colitis.

Bu Pi Jian Chang Wan adopts an innovative TCM formular originally created by Chenliji, which is able to alleviate the symptoms of colitis while giving radical treatment. Because of its curative effect and low side effect, the drug is loved by both doctors and patients.

The winning project aims to industrialize the patent technology of Bu Pi Jian Chang Wan, targeting key technology in the process of production, quality evaluation & control and pharmacological mechanism.

The project is expected to improve the product’s safety, stability and technology, and further testify its effectiveness. It will help more patients with digestive diseases to alleviate pain and improve their life quality.

Baiyunshan Chenliji has been upgrading its technology in recent years and established a series of provincial and municipal innovative platforms. Chenliji’s research team consists of members with doctoral degrees, master degrees and senior engineering certificate, contributing to a variety of awards, papers and patents.